NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-28 10:35இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Mastek Q2 Earnings Call: Revenue Up 2.4% QoQ to $107.3M; Bidding for >£100M UK Deal
Mastek reported Q2 revenue of $107.3 million, growing 2.4% QoQ in constant currency, while EBITDA margins dropped approximately 100 bps QoQ to 14.4% due to salary revisions. The 12-month order backlog grew 2.3% YoY, supported by North American backlog growing over 50% YoY, though UK order intake faced delays around government budget transitions. Management highlighted that it secured a short-term bridge contract for the UK NHS account and is competing for an upcoming renewal contract valued north of £100 million. Subcontractor costs remained at 18-20% of revenue, with potential short-term volatility due to UK localization requirements.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript for the Q2 FY27 earnings conference call held on October 26, 2026.
ஏன் இது முக்கியம்Provides granular operational color on North American growth acceleration, UK public sector pipeline timing, and the bidding status of mega NHS contracts.
Q2 வருவாய்: $107.3 millionEBITDA லாப வரம்பு: 14.4%QoQ Revenue Growth (CC): 2.4%Order Backlog Growth YoY: 2.3%Prospective Contract Size: north of 100 million pounds
📅 குறுகிய காலம்Margins will reflect salary hike impacts, while order book conversion in the UK may pick up post-budget policy clarity.
📈 நீண்ட காலம்Growth hinges on expanding beyond traditional UK government exposure into North America and AI-native service offerings.
⚠ அபாய எச்சரிக்கைகள்
Geographic concentration in UK public sector (~57% revenue from UK/Europe)
Delays or shifts in UK government IT project awards
Margin compression from wage revisions and potential subcontractor localization demands
👀 கவனிக்க வேண்டியவை
Track conversion and outcome of the >£100 million UK public sector contract in H2, alongside margin trajectory post-salary hikes.
Mastek Q2FY27 Revenue Up 3.4% QoQ to ₹1,018.7 Cr; 12-Month Order Backlog at ₹2,742.8 Cr
Mastek reported a 3.4% sequential and 8.3% YoY rise in consolidated revenue from operations to ₹1,018.7 crore ($107.3 million) for Q2FY27. Operating EBITDA declined 3.9% QoQ to ₹146.2 crore, leading to an EBITDA margin contraction of 109 bps to 14.4%, primarily driven by annual increments. Net profit remained flat QoQ at ₹105.7 crore (up 8.4% YoY) with diluted EPS at ₹33.9. The 12-month order backlog grew 10.4% YoY in rupee terms to ₹2,742.8 crore ($286.2 million), representing ~72.8% of TTM revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek released its Q2FY27 investor presentation and earnings results showing steady topline growth crossing ₹1,000 crore, offset by wage-driven margin compression.
ஏன் இது முக்கியம்Demonstrates resilience in UK/Europe and growing AI pipeline (~45% of order book), though EBITDA margin compressed to 14.4% due to cost headwinds.
Revenue from Operations (Q2FY27): ₹1,018.7 கோடிOperating EBITDA Margin: 14.4%Net Profit (Q2FY27): ₹105.7 கோடி12-Month Order Backlog: ₹2,742.8 கோடிBacklog vs TTM Revenue: ~72.8%LTM Attrition Rate: 15.2%
📅 குறுகிய காலம்Stock reaction may be muted given in-line top-line growth accompanied by a 109 bps QoQ margin dip due to annual wage increments.
📈 நீண்ட காலம்Growing AI traction (53 new deals) and geographic diversification beyond the UK toward the US healthcare and commercial enterprise market are key strategic drivers.
⚠ அபாய எச்சரிக்கைகள்
EBITDA margin contraction of 109 bps QoQ
Middle East region business continues to face geopolitical uncertainties
High client and regional concentration in UK public sector/healthcare
👀 கவனிக்க வேண்டியவை
Track margin recovery in upcoming quarters post-increments and monitor conversion of the $286.2 million order backlog, particularly in the US healthcare and AI-led engagements.
Mastek Q2 Standalone Net Profit Rises to ₹62.2 Cr Aided by ₹47.3 Cr Property Sale Gain
Mastek reported standalone revenue from operations of ₹237.52 cr for Q2 ended September 30, 2026, an increase of 7.3% QoQ from ₹221.32 cr. Standalone net profit reached ₹62.22 cr compared to ₹20.80 cr in Q1, heavily boosted by net exceptional items of ₹43.78 cr. The exceptional items included a ₹47.26 cr gain from the sale of a Chennai property, offset by a ₹10.64 cr AI-led restructuring cost and ₹25.90 cr in bad debts written off across US and AMEA regions.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek released its Q2 FY27 unaudited standalone results, recording a large non-operational asset sale gain and bad debt write-offs.
ஏன் இது முக்கியம்Core profit growth was masked by significant exceptional items, showing persistent credit costs in the US and AMEA segments alongside one-off restructuring charges.
Standalone Revenue (Q2): 23,752 லட்சம்Standalone Net Profit (Q2): 6,222 லட்சம்Gain on sale of Chennai property: 4,726 லட்சம்Bad debts written off: 2,590 லட்சம்AI restructuring cost: 1,064 லட்சம்
📅 குறுகிய காலம்Market focus will likely adjust for the ₹47.26 cr non-operating property sale to evaluate core operational performance and operating margins.
📈 நீண்ட காலம்Efficiencies from the ₹10.64 cr AI-led operational restructuring need to be monitored against ongoing bad debt risks in international geographies like the US.
⚠ அபாய எச்சரிக்கைகள்
High exceptional write-offs of unbilled/receivables (₹25.90 cr) indicating credit or billing risks in US and AMEA
Reported earnings boosted by non-recurring asset sale
👀 கவனிக்க வேண்டியவை
Track the full consolidated performance and management commentary on organic margin trajectory after stripping out one-off property sale gains and bad debt write-offs.
Mastek Selected by UK's Staffordshire County Council for AI-Enabled Oracle Cloud Transformation
Mastek (UK) Limited, a wholly owned subsidiary of Mastek Limited, has secured a digital transformation contract from Staffordshire County Council. The council serves over 875,000 residents across England. Mastek will deploy its proprietary ADOPT-AI platform to integrate Oracle Cloud across Finance, Procurement, HR, and Payroll services. Contract value and implementation timeline were not disclosed in the announcement.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுStaffordshire County Council selected Mastek to drive its enterprise-wide Oracle Cloud transformation programme.
ஏன் இது முக்கியம்The deal reinforces Mastek's footprint in the UK public sector, which, together with healthcare, represents over 50% of the company's total revenues.
Population served by client: more than 875,000 residentsடீல் மதிப்பு: வெளியிடப்படவில்லைMastek global workforce: close to 5,000 employeesMastek active customer base: 400+ active customers
📅 குறுகிய காலம்Positive for market sentiment regarding Mastek's order pipeline in the UK, though financial impact remains unquantified due to lack of deal size disclosures.
📈 நீண்ட காலம்Strengthens referenceability in UK local council reorganisations and deepens Oracle Cloud migration credentials, aligning with enterprise AI positioning.
⚠ அபாய எச்சரிக்கைகள்
Deal value not disclosed
High geographical and sector concentration risk given UK public sector accounts for a dominant share of revenue
👀 கவனிக்க வேண்டியவை
Track quarterly order intake and backlog figures in upcoming earnings calls to assess the commercial contribution and margin impact of this UK public sector win.
Mastek Concludes Chennai Commercial Property Sale for ₹60 Cr
Mastek Limited has completed the sale of its commercial building comprising approximately 1,57,233 sq. ft. on 15.50 acres of leased land at Mahindra World City SEZ, Chennai. The company received total cash consideration of ₹60 crore in two tranches from buyer Caresoft Mobility Private Limited. The transaction was finalized on August 17, 2026, at arm's length with an unrelated party. The ₹60 crore consideration represents ~6.9% of Mastek's net worth (₹868 crore) and unlocks capital from non-core real estate.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek has fully executed and completed the sale of its Chennai SEZ commercial property to Caresoft Mobility for ₹60 crore.
ஏன் இது முக்கியம்The sale monetizes non-core physical real estate, adding ₹60 crore (~6.9% of net worth) in liquidity without affecting core software delivery operations.
Total consideration: ரூ. 60 கோடிConsideration vs Net worth: ~6.9%Built-up area: 1,57,233 Sq. Ft.Leased land area: 15.50 acresCompletion date: ஆகஸ்ட் 17, 2026
📅 குறுகிய காலம்May reflect as an exceptional item/one-off cash inflow in Q2 FY27 earnings, slightly boosting cash reserves.
📈 நீண்ட காலம்Limited structural impact on core IT consulting business; aligns with maintaining an asset-light balance sheet.
👀 கவனிக்க வேண்டியவை
Track the upcoming quarterly financial results for any one-time exceptional gain or loss recognized from this asset disposal and how the cash proceeds are redeployed.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
₹16 Final Dividend: Mastek Sets August 31, 2026, as Record Date
Mastek Limited has fixed August 31, 2026, as the record date to determine eligibility for a final dividend of ₹16 per equity share for FY25-26. This dividend was previously recommended by the Board on April 17, 2026, and is subject to shareholder approval at the 44th Annual General Meeting (AGM) on September 7, 2026. Based on the TTM EPS of ₹130.42, this represents a payout ratio of approximately 12.3%. The dividend yield at the current price of ₹1812.6 is approximately 0.88%.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has officially scheduled its 44th AGM and finalized the record date for the final dividend recommended earlier in April 2026.
ஏன் இது முக்கியம்This is a routine capital allocation event, providing a cash return to shareholders. The payout is well-covered by the company's annual net profit of ₹403.2 Cr (FY26).
Final Dividend: ₹16 per shareரெக்கார்ட் தேதி: ஆகஸ்ட் 31, 2026டிவிடெண்ட் ஈல்ட்: ~0.88%Payout vs TTM EPS: ~12.3%AGM Date: செப்டம்பர் 7, 2026
📅 குறுகிய காலம்The stock price may see a minor adjustment on the ex-dividend date (typically one business day prior to the record date) reflecting the ₹16 payout.
📈 நீண்ட காலம்Limited; this is a routine procedural filing for a scheduled dividend payment.
👀 கவனிக்க வேண்டியவை
Investors should note the record date of August 31, 2026; shares must be held in the demat account by this date to receive the ₹16 dividend. Monitor the AGM outcomes on September 7 for formal approval.
Mastek Signs Platinum Partnership with Innovaccer for AI Healthcare across 4 Global Regions
Mastek has entered a strategic Platinum Partnership with Innovaccer to implement the 'Gravity' healthcare intelligence platform globally. The partnership targets healthcare organizations in North America, UK, Europe, and the Middle East, focusing on AI-driven data unification. This move aligns with Mastek's strategy to diversify its revenue base, which currently sees over 50% concentration in the UK Public/Healthcare sectors. While no specific contract value was disclosed, the partnership leverages Mastek's 5,000-strong workforce and 400+ active customer base to scale AI transformation.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek has formalized a high-tier global partnership with Innovaccer, moving from a general service provider to a specialized implementation partner for AI-driven healthcare platforms.
ஏன் இது முக்கியம்Healthcare is a critical vertical for Mastek, with the UK NHS being a major client; this partnership provides a structured path to expand into the US healthcare market and reduce UK dependency.
📅 குறுகிய காலம்The announcement is sentiment-positive as it reinforces Mastek's 'AI-first' positioning and strategic focus on the high-growth healthcare vertical.
📈 நீண்ட காலம்If executed well, this partnership could structurally improve Mastek's margins and geographic mix by capturing higher-value AI transformation projects in the US and Middle East.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in scaling a third-party platform
Intense competition in the US healthcare IT market
No immediate quantified order value
👀 கவனிக்க வேண்டியவை
Monitor the conversion of this partnership into tangible order wins in the US healthcare sector in upcoming quarterly results to validate the company's geographic diversification strategy.
Mastek Q1 FY27: 25% YoY Order Backlog Growth and $25M AI Deal in North America
Mastek reported a steady Q1 FY27 with revenue reaching $104.8 million, a 1.2% sequential increase in USD terms. The 12-month order backlog showed strong momentum, growing 25% YoY (13% in constant currency), providing significant revenue visibility. A key highlight was a $25 million AI transformation deal in North America, the largest in recent quarters, helping offset headwinds in the Middle East. Management is pivoting the company toward an 'AI transformation' focus, supported by the appointment of a new COO from LTIMindtree.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek is transitioning from a traditional engineering services provider to an AI-led transformation company, evidenced by a major $25M AI deal and internal AI-led process automation.
ஏன் இது முக்கியம்The 25% backlog growth provides strong revenue visibility for the next 12 months. The shift toward AI-led deals is critical to maintaining competitiveness and protecting margins against pricing pressures in legacy services.
Q1 வருவாய்: $104.8 million12-Month Order Backlog Growth (YoY): 25%Large AI Deal Value: $25 millionDeal vs TTM Revenue: ~5.6%Operating EBITDA Margin: 15.4%UK Constant Currency Growth (QoQ): 3%
📅 குறுகிய காலம்The stock may see positive sentiment driven by the strong backlog and the large $25M deal win, though Middle East volatility remains a minor drag.
📈 நீண்ட காலம்The structural pivot to AI and increasing US market share (currently ~27%) are key to long-term growth and reducing dependency on UK public sector spending.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical volatility in the Middle East impacting regional revenue
AI-led competition challenging incumbents in existing accounts
UK government policy/budget changes following leadership transition
👀 கவனிக்க வேண்டியவை
Monitor the execution timeline of the $25 million North America deal and the impact of the new COO on delivery efficiency. Watch for stabilization in the Middle East business and any budget shifts from the new UK government.
25% YoY Order Backlog Growth to Rs 2,935 Cr; Q1 Revenue Up 5% QoQ
Mastek reported a resilient Q1FY27 with revenue reaching Rs 985.3 crore, a 5% sequential growth. The 12-month order backlog grew significantly by 25% YoY to Rs 2,935.2 crore, representing approximately 79% of TTM revenue, which provides strong visibility. While EBITDA margins contracted slightly to 15.4% due to Middle East collection delays, the company secured major AI-led wins, including a $25 million deal in North America. Cash reserves improved to Rs 945.4 crore, strengthening the balance sheet for future growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek has pivoted its strategy to 'Lead with AI', with AI deals now making up nearly half of new orders, and has achieved a record order backlog of nearly Rs 3,000 crore.
ஏன் இது முக்கியம்The high order backlog (79% of TTM revenue) provides high revenue predictability, while the shift to AI-led services helps maintain competitive relevance and supports the company's goal of geographic diversification into the US market.
Q1FY27 Revenue: Rs 985.3 கோடிOrder Backlog vs TTM Revenue: 79.3%EBITDA லாப வரம்பு: 15.4%Cash and Investments: Rs 945.4 கோடிNew AI Deal Share: 45%
📅 குறுகிய காலம்Positive sentiment is expected due to strong order booking and sequential revenue growth in key markets like the UK and US, despite minor margin pressure.
📈 நீண்ட காலம்The structural shift towards AI and cloud transformation, coupled with a robust cash position and reducing UK dependency, positions the company for steady long-term growth.
⚠ அபாய எச்சரிக்கைகள்
Geopolitical uncertainty in the Middle East impacting collections and margins
High concentration in UK public sector and healthcare
Pricing pressures from global IT peers
👀 கவனிக்க வேண்டியவை
Monitor the conversion of the record order backlog into revenue and the stabilization of margins, particularly in the Middle East business which is facing geopolitical headwinds. Watch for the execution of the $25 million North American deal as a benchmark for AI-led growth.
Mastek Q1 FY27 Revenue up 7.7% YoY to ₹985.25 Cr; PBT Grows 14.7%
Mastek Limited reported a steady start to FY27 with revenue from operations reaching ₹985.25 Cr, a 5.0% sequential growth from the previous quarter. Profit Before Tax (PBT) stood at ₹138.46 Cr, reflecting a 14.7% increase compared to ₹120.70 Cr in the same quarter last year. Employee benefit expenses remain the primary cost driver at ₹532.56 Cr, accounting for approximately 54% of total revenue. The company also updated its fair disclosure code for price-sensitive information to align with regulatory standards.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe filing represents the release of Q1 FY27 financial results and an amendment to the company's internal code for fair disclosure of price-sensitive information.
ஏன் இது முக்கியம்The results demonstrate Mastek's ability to maintain mid-single-digit sequential growth and improve profitability despite a challenging global IT environment and high concentration in the UK public sector.
Revenue (Q1 FY27): ₹985.25 கோடிRevenue vs TTM Revenue: ~26.6%PBT Growth (YoY): 14.7%Employee Cost to Revenue: 54.1%பிற வருமானம்: ₹12.03 கோடி
📅 குறுகிய காலம்The stock may see positive sentiment in the short term due to steady revenue growth and the absence of exceptional losses that impacted the previous quarter.
📈 நீண்ட காலம்Long-term value depends on the successful integration of acquisitions like BizAnalytica and the ability to scale the US business beyond the current 27.2% revenue share.
⚠ அபாய எச்சரிக்கைகள்
High employee cost concentration (54% of revenue)
Significant revenue dependency on UK/Europe markets (~57%)
Pricing pressures from global IT peers
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming management commentary regarding the 12-month order backlog and the progress of US market expansion, which is a key strategic goal to reduce UK dependency.
10M Tonne Operations: Mastek Partners with Yanbu Cement for Digital Transformation
Mastek has entered into a strategic partnership with Yanbu Cement Company (YCC), a major Saudi Arabian cement manufacturer, to modernize its production-to-dispatch operations. The project involves digitizing a facility that handles over 10 million tonnes of cement and 220,000 truck movements annually. While the specific contract value was not disclosed, the implementation utilizes Oracle Fusion Cloud ERP and Industrial IoT to automate mission-critical workloads. This deal reinforces Mastek's strategy to expand its footprint in the Middle East and leverage its Oracle Cloud expertise.
உச்சம் நம்பிக்கை
என்ன மாறியதுMastek has secured a high-profile industrial IoT and ERP integration contract with a leading Saudi cement manufacturer, moving beyond traditional IT services into heavy industry automation.
ஏன் இது முக்கியம்The partnership demonstrates Mastek's ability to execute complex 'Industry 4.0' projects in the Middle East, a key growth market for diversifying revenue away from its heavy UK public sector dependency (currently >50%).
📅 குறுகிய காலம்The announcement is likely to be viewed positively as it validates Mastek's 'Lead with AI' and IoT capabilities in a competitive international market.
📈 நீண்ட காலம்If successfully scaled, such industrial partnerships could improve Mastek's operating margins (currently 15.8%) by shifting the mix toward higher-value digital engineering and IoT solutions.
⚠ அபாய எச்சரிக்கைகள்
Lack of disclosed contract value
Execution risks in complex IoT-ERP integration
Geopolitical/regional concentration in the Middle East
👀 கவனிக்க வேண்டியவை
Investors should monitor the AMEA (Asia, Middle East, Africa) region's revenue growth in upcoming quarterly filings to assess the financial scale of such industrial digital transformation contracts.
Mastek Receives ₹123.58 Crore Income Tax Assessment Order; Company to Appeal
Mastek Limited has received a Final Assessment Order from the Income Tax Department for FY 2022-23, involving a total income addition of ₹123.58 crore. The order includes a transfer pricing adjustment of ₹90.95 crore and domestic tax additions of ₹32.63 crore, alongside initiated penalty proceedings. The company has identified several computation errors in the order, such as incorrect tax rates and the non-allowance of foreign tax credits. Mastek intends to contest the order before the Income Tax Appellate Authorities and currently expects no material financial impact.
முக்கிய அம்சங்கள்
Total income addition of ₹1,23,58,26,194 (approx. ₹123.58 crore) for FY 2022-23.Transfer pricing adjustments account for ₹90.95 crore of the total addition.Penalty proceedings have been initiated under Section 270A of the Income Tax Act.Company claims significant computation errors, including non-grant of credit for advance tax paid by an amalgamated subsidiary.Mastek plans to file objections/responses with the Income Tax Appellate Authorities within prescribed timelines.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the tax appeal as the ₹123.58 crore addition is significant, though the company's claim of computation errors suggests the final liability may be lower.
Mastek Receives ₹123.58 Cr Income Tax Assessment Order; Company to File Objections
Mastek Limited has received a Final Assessment Order for FY 2022-23 from the Income Tax Department, involving a total income addition of ₹123.58 crore. The order includes a transfer pricing adjustment of ₹90.95 crore and domestic tax additions of ₹32.63 crore, alongside the initiation of penalty proceedings. The company has identified several errors in the tax computation, such as the non-allowance of foreign tax credits and advance tax credits from an amalgamated subsidiary. Mastek intends to challenge the order before the Income Tax Appellate Authorities and currently expects no material financial impact.
முக்கிய அம்சங்கள்
Total income addition of ₹123.58 crore for the financial year 2022-23.Includes ₹90.95 crore in transfer pricing adjustments and ₹32.63 crore under domestic tax laws.Income Tax Department has initiated penalty proceedings under Section 270A.Company claims computation errors regarding tax rates and non-grant of credit for advance tax paid by an amalgamated subsidiary.Mastek will file objections with the Income Tax Appellate Authorities within prescribed timelines.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the appellate proceedings as the contested amount is significant. However, the company's claim of computational errors suggests potential for a favorable rectification or stay.
Mastek Appoints Amit Gajwani as COO; Succeeds Prameela Kalive
Mastek has appointed Amit Gajwani as Chief Operating Officer to drive its AI-first transformation and global operations. Gajwani brings over 28 years of experience, including a successful tenure at LTM Limited where he built the Europe business unit into a high-growth vertical. He succeeds Prameela Kalive, who will stay until June 2026 to ensure a smooth leadership transition. This move aims to strengthen Mastek's execution across its 40+ country footprint and 400+ active customer base.
முக்கிய அம்சங்கள்
Amit Gajwani joins as COO with 28+ years of global leadership experience in IT servicesPreviously served as Head of Europe at LTM Limited, scaling the business from the ground upOutgoing COO Prameela Kalive to remain until June 30, 2026, for a seamless transitionMastek currently manages a workforce of nearly 5,000 employees across 40 countriesThe company maintains a portfolio of 400+ active customers globally
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step in strengthening the leadership pipeline with a veteran known for scaling international markets. Monitor the upcoming quarterly results for any commentary on operational efficiency improvements under the new leadership.
Mastek Limited has entered into a Memorandum of Understanding (MOU) to sell its commercial building and leased land located at Mahindra World City, SEZ, Chennai. The transaction involves a built-up area of approximately 1,57,233 Sq. Ft. on 15.50 acres of land for a total consideration of Rs 60 crore. The buyer, Caresoft Mobility Private Limited, is a non-related party, and the payment will be received in two tranches. This divestment represents a monetization of real estate assets, likely aimed at improving the company's liquidity or capital allocation efficiency.
முக்கிய அம்சங்கள்
Sale of commercial building with 1,57,233 Sq. Ft. built-up area on 15.50 acres of leased land.Total aggregate consideration of Rs 60 crore to be received in two tranches.Buyer identified as Caresoft Mobility Private Limited, confirming no related party involvement.Asset located in Mahindra World City, SEZ, Chengalpattu, Chennai.Transaction is subject to necessary regulatory approvals and SEZ compliances.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move to unlock value from non-core assets. Watch for updates on the final sale agreement and how the company plans to utilize the Rs 60 crore cash inflow.
Mastek Q4 FY26: Revenue up 3.6% QoQ to ₹938 Cr; Order Backlog Grows 13.5% YoY to $300M
Mastek reported a stable Q4 FY26 with revenue reaching $103.5 million and a steady EBITDA margin of 16.1%. The company's 12-month order backlog grew significantly to $300.4 million, providing strong visibility for FY27 despite global macroeconomic headwinds. While the US market underwent a strategic reset, the UK business remained a major growth driver, particularly in the healthcare sector. Management declared a final dividend of ₹16 per share, bringing the total FY26 payout to ₹24 per share.
முக்கிய அம்சங்கள்
12-month order backlog reached $300.4 million, representing a 13.5% YoY increase in USD terms.Full-year FY26 revenue stood at $421.2 million, up 3.1% YoY, with EBITDA margins maintained at 15.8%.UK & Europe business grew 21.8% in INR terms, driven by a 24% USD growth in the healthcare vertical.Days Sales Outstanding (DSO) improved to 73 days, the lowest level recorded in the last 12 quarters.Recognized a total exceptional impact of ₹30 crore for Labor Code changes, fully reflected in the FY26 financials.
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the strong order book in H1 FY27 and the expected turnaround in the North American geography. The stock remains a steady play on UK public sector spending and AI-driven operational efficiency.
Mastek Q4 Net Profit Jumps 31% YoY to ₹106 Cr; Order Backlog Grows 24% to ₹2,849 Cr
Mastek reported a resilient Q4FY26 with revenue growing 3.6% YoY to ₹938 crore and a significant 30.9% surge in net profit to ₹106.2 crore. The company's 12-month order backlog reached a robust ₹2,849.2 crore, marking a 24.4% YoY growth, driven by strong performance in the UK and US markets. AI adoption is a key growth driver, with over 25 AI-assisted deals closed in the quarter and a 12% improvement in revenue per employee. The board has recommended a final dividend of ₹16 per share, bringing the total FY26 payout to 480%.
முக்கிய அம்சங்கள்
Q4FY26 Net Profit rose 30.9% YoY to ₹106.2 crore, while Revenue from Operations grew 3.6% YoY to ₹938 crore.12-month order backlog grew by 24.4% YoY in rupee terms to ₹2,849.2 crore ($300.4 mn).Operating EBITDA margin remained steady at 16.1% for Q4, despite absorbing annual wage revisions.Closed 25+ AI-assisted deals in Q4, totaling 85+ for FY26, leading to a 12% improvement in revenue per employee.Recommended a final dividend of ₹16 per share, taking the total dividend for FY26 to 480%.
👀 கவனிக்க வேண்டியவை
Investors should focus on the strong 24.4% growth in the order backlog and the successful 'Lead with AI' strategy which is improving productivity. The robust cash balance of ₹938.5 crore and increased dividend payout reflect strong financial health and management confidence.
Mastek Recommends Final Dividend of Rs. 16 per Share; Total FY26 Dividend at Rs. 24
Mastek Limited's Board has recommended a final dividend of Rs. 16 per equity share for the financial year ended March 31, 2026. When combined with the interim dividend of Rs. 8, the total dividend for FY 2025-26 stands at Rs. 24 per share, marking an increase from Rs. 23 in the previous year. The company also approved its annual audited financial results, which received an unmodified opinion from statutory auditors. The dividend payment is subject to shareholder approval at the upcoming 44th Annual General Meeting.
முக்கிய அம்சங்கள்
Recommended final dividend of Rs. 16 per equity share (320% of face value of Rs. 5)Total dividend for FY 2025-26 is Rs. 24 per share (480%), compared to Rs. 23 (460%) in FY 2024-25Statutory auditors Walker Chandiok & Co LLP issued an unmodified audit opinion on financial statementsDividend to be paid within 30 days of approval at the 44th Annual General MeetingFinancial results include the restated impact of the merger with Mastek Enterprise Solutions Private Limited
👀 கவனிக்க வேண்டியவை
Investors should hold for the dividend payout which reflects a steady yield and consistent payout policy. Monitor the upcoming announcement regarding the record date to ensure eligibility for the final dividend.
Mastek Secures £15 Million Digital Engineering Contract with UK's Financial Conduct Authority
Mastek's UK subsidiary has secured a £15 million contract with the Financial Conduct Authority (FCA) to support its Digital Delivery Hub. The initial engagement is for two years, with a potential for a two-year extension, focusing on engineering and development work. This partnership underscores Mastek's expertise in handling complex, compliance-heavy transformation programs for critical national infrastructure. The deal aligns with the UK government's regulatory modernization efforts and strengthens Mastek's footprint in the UK public sector.
முக்கிய அம்சங்கள்
Initial contract value of £15 million over a two-year period.Potential for a 2-year extension beyond the initial term.Project involves supporting the FCA’s Digital Delivery Hub for engineering and development work.Strengthens Mastek's presence in the UK public sector and regulatory modernization space.The contract is part of the UK's Critical National Importance agenda for financial infrastructure.
👀 கவனிக்க வேண்டியவை
This contract win provides revenue visibility and enhances Mastek's reputation in the high-margin UK public sector. Investors should maintain a positive outlook as the company continues to win specialized digital transformation deals.
Mastek Secures £85m ($110m+) Engineering Contract with UK Home Office
Mastek's UK subsidiary has secured a major framework engineering contract worth approximately £85 million (over $110 million) with the UK Home Office. The engagement focuses on scaling, maintaining, and enhancing the ATLAS platform, which is critical for UK visa, asylum, and border operations. Mastek will deploy AI-driven engineering accelerators and automation to modernize the platform's infrastructure. This contract reinforces Mastek's strong foothold in the UK public sector and provides significant revenue visibility for the coming years.
முக்கிய அம்சங்கள்
Total contract value estimated at circa £85 million ($110 million+).Focuses on the UK Home Office's ATLAS platform for Migration & Borders Technology.Utilizes AI-first digital engineering and automation for platform modernization.Supports critical national functions including Visa routes, Asylum Casework, and Border Force Operations.Management expects significant growth within this contract as more complex policies are onboarded.
👀 கவனிக்க வேண்டியவை
This is a significant win that strengthens Mastek's core UK public sector business; investors should monitor for margin improvements and further order book growth. The stock may see positive momentum given the large deal size relative to the company's annual revenue.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
